Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia	JOURNAL OF INFECTION	2016
Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2016
Reply to. "monitoring antivitamin K anticoagulants in antiphospholipid syndrome. a challenge in quality"	ATHEROSCLEROSIS	2016
Is there an interplay between adherence to mediterranean diet, antioxidant status, and vascular disease in atrial fibrillation patients?	ANTIOXIDANTS & REDOX SIGNALING	2016
Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2016
Age-related increase of thromboxane B2 and risk of cardiovascular disease in atrial fibrillation	ONCOTARGET	2016
Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease	INTERNATIONAL JOURNAL OF CARDIOLOGY	2016
Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2016
Interaction between dietary Vitamin K intake and anticoagulation by Vitamin K antagonists: is it really true?: A systematic review	MEDICINE	2016
HIV-1 induces in vivo platelet activation by enhancing platelet NOX2 activity.	JOURNAL OF INFECTION	2015
Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation	THROMBOSIS AND HAEMOSTASIS	2015
The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease	DIGESTIVE AND LIVER DISEASE	2015
Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation	INTERNATIONAL JOURNAL OF CARDIOLOGY	2015
Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients.	INTERNATIONAL JOURNAL OF CARDIOLOGY	2015
Relation of Nonalcoholic Fatty Liver Disease and Framingham Risk Score to Flow-Mediated Dilation in Patients With Cardiometabolic Risk Factors	THE AMERICAN JOURNAL OF CARDIOLOGY	2015
Nox-2 up-regulation and platelet activation: Novel insights.	PROSTAGLANDINS & OTHER LIPID MEDIATORS	2015
Does mediterranean diet reduce cardiovascular events and oxidative stress in atrial fibrillation	ANTIOXIDANTS & REDOX SIGNALING	2015
Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".	INTERNATIONAL JOURNAL OF CARDIOLOGY	2015
Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients	AMERICAN HEART JOURNAL	2015
Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events	THE AMERICAN JOURNAL OF CARDIOLOGY	2015

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.